Please login to the form below

Not currently logged in

BioNTech forecasts €9.8bn in sales of Pfizer-partnered COVID-19 vaccine in 2021

BiontechCompany also raised full year manufacturing capacity target for vaccine to 2.5 billion doses

Amgen plans acquisition of Rodeo Therapeutics

Amgen flagDeal could be worth over $700m including potential future milestone payments

AstraZeneca to supply US government with 500,000 additional doses of its COVID-19 antibody

AZ NEWAZD7442 is a long-acting antibody combination that could help to prevent and treat COVID-19

Roche buys GenMark for $1.8bn to bolster diagnostics portfolio

Swiss pharma company will gain respiratory pathogen panels to strengthen its COVID-19 testing capabilities

Amgen adds to oncology pipeline with $1.9bn Five Prime Therapeutics acquisition

Amgen flagFive Prime's pipeline includes potentially first-in-class anti-FGFR2b antibody bemarituzumab

AbbVie buys exclusive right to acquire Mitokinin’s Parkinson’s asset

AbbVie buildingCompany can acquire asset following the completion of IND enabling studies

Merck & Co to help produce J&J’s COVID-19 vaccine in the US

COVID-19 vaccineCompany has signed agreements to bolster vaccine manufacturing capacity

Merck KGaA gains exclusive rights to Debiopharma’s late-stage oncology asset

Merck KGaADevelopment and commercialisation deal could be worth up to $1.08bn

Business in the USAHealth coverage across state lines

Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad

  • Ho_Ung_KimStanding out in a crowd

    Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars

  • HeadsThe diseased organisation

    Like humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...
InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...